Valoe Corporation's Half-Year Financial Report January - June 2024
Valoe
Corporation Half-Year
Report 30 September
2024 at 19.10 Finnish time
THE FIRST HALF OF THE YEAR 2024 IN BRIEF
In January - September 2024, the net sales of Valoe Group, under
the IFRS standards, were EUR about 0.2 million (in 2023 EUR 0.9
million). The EBITDA was about EUR -1.0 million (EUR -1.5 million),
the EBIT was ca. EUR -1.7 million (EUR -2.4 million), and the
profit for the period was ca. EUR -2.0 million (EUR -3.2 million).
At the end of the reporting period, Valoe Group’s equity ratio
including capital loans was -47.6 per cent.
(-20.0 %).
The District Court of Pohjois-Savo decided on the commencement
of the restructuring proceedings of Valoe Corporation on 22 January
2024.
Mr Pekka Jaatinen, Attorney, (”Administrator”) submitted his
preliminary report in accordance with the Restructuring of
Enterprises Act on 22 February 2024. At the end of the reporting
period, on 24 June 2024, the Administrator filed a proposal for the
restructuring programme for the company with the North Savo
District Court. The objective of the restructuring programme is to
restore the Company’s business, maintain its competitiveness in its
industry and restructure the Company's debts only to the extent
necessary to achieve the Company's restructuring objective. Valoe
disclosed the main content of the restructuring programme proposal
on 24 June 2024. As per the date of this Report, the restructuring
programme proposal has not yet been confirmed.
On 27 May 2024, Valoe disclosed that the company’s Board of
Directors had discovered that the company had negative equity and
had filed a notice of the loss of share capital with the Finnish
Trade Register.
Valoe does not have an auditor and thus the company's financial
statements for 2023 have not been audited. Therefore, the agenda
items related to the financial statements, the use of the loss for
2023, the dividend payment, and the discharge were not discussed at
the Annual General Meeting. It was resolved to adjourn the Annual
General Meeting and postpone the discussion of the items
above-mentioned, as well as the decision on the remuneration and
election of the auditor, to a follow-up meeting. The Board of
Directors will convene a follow-up meeting at a date to be
announced later.
In a challenging financial situation, the company has continued
temporary layoffs throughout the reporting period.
Trading in the company’s shares has been suspended since 5
December 2023, which continues as per the date of this Review.
THE MAIN EVENTS AFTER THE REPORTING PERIOD
In Valoe’s restructuring proceedings, the deadline for
submitting statements concerning the draft restructuring programme
expired on 22 July 2024. However, the District Court of North Savo
granted an extension to the deadline for submitting statements
until 15 August 2024 in accordance with a request of a creditor.
After the aforementioned extension period, the administrator will
prepare the report on the claims and statements received under the
Restructuring of Enterprises Act and, if necessary, propose changes
to the draft restructuring programme.
At the end of July 2024, the company extended the subscription
period of the Convertible Bond 1/2023 disclosed on 14 July 2023
until 30 September 2024. On 30 September 2024, the company extended
the subscription period again until 31 December 2024.
In July 2024, Ilmarinen Mutual Pension Insurance Company filed a
petition for Valoe’s bankruptcy, which was withdrawn after Valoe
paid its debt to Ilmarinen Mutual Pension Insurance Company.
Mr. Jose Basso, Senior Vice President for Valoe’s solar cell
business in Lithuania, has filed for the company's bankruptcy. The
application relates to claims arising from an agreement between the
Company and Mr. Basso, with the claim amount being approximately
EUR 60,000. The claims are disputed and Valoe has opposed the
application. The agreement between the parties has been terminated
on 31 May 2024.
MANAGING DIRECTOR IIKKA SAVISALO’S REPORT
Following a delay in the financing negotiations at the end of
2023, we commenced cutting operational costs sharply to reduce
working capital needs. However, in December 2023, we had to file an
application for restructuring. Our limited resources are now
focused on serving the most promising client relationships. These
include major accounts in the automotive industry and projects in
the electronics and space industry. In the second quarter, Valoe
delivered VIPV (vehicle-integrated Photovoltaics) prototypes to two
prominent tier-1 suppliers. Both prototypes successfully met the
targets set for the development phase.
Valoe also delivered prototypes of solar energy applications for
portable electronics and constellation satellites. The customers
included a major military and space company, as well as a prominent
consumer electronics brand.
Despite the difficult financial situation, we managed to
continue our operations and development work, focusing only on our
key accounts. Nowadays, also the development activities have almost
come to a halt.
We are actively negotiating with several domestic and foreign
investors for financing solutions to support a restructuring
program that will ensure the future of the company. However, these
financing negotiations have taken longer than expected, which has
increased the risk of suspending the restructuring proceedings.
VALOE’S FUTURE OUTLOOK
The delay in securing financing solutions casts a shadow over
Valoe’s future prospects, forcing the company to almost halt its
operations for the time being. There is currently no certainty
about the continuation of operations.
However, solar energy solutions for the automotive industry,
electronics, and satellites require technology that significantly
differs from conventional solar panels. This technology suits very
well the company’s capabilities. If a financing solution is
secured, the company’s strategy is clear: we will continue working
with our key customers to bring products to the mass market. We
believe that the first mass production agreements could be reached
approximately in six months after securing financing.
We are currently negotiating several different financing
options, some of which are very close to a resolution. However, if
a financing solution is not found very soon, the restructuring
proceedings may be interrupted, and the company could face
bankruptcy.
MARKET GUIDANCE
Valoe will not disclose any market guidance for the financial
year 2024 due to the restructuring proceedings.
FINANCIAL RESULT
Valoe Group’s cumulative net sales for the first half of 2024
were about EUR 0.1 million. The net sales decreased by about 82 per
cent compared to the previous year.
The following financials include Valoe Group’s operations. The
figures in brackets are comparison figures for the corresponding
period in 2023 unless stated otherwise.
April - June 2024:
- Valoe Group’s net sales was to EUR 0.07 million (In 2023: EUR
0.5 million).
- EBITDA was EUR -0.5 million (EUR -0.6 million).
- Operating profit was EUR -0.9 million (EUR -1.1 million).
- Profit for the period was EUR -0.9 million (EUR -1.4
million).
January – June 2024:
- Valoe Group’s net sales decreased to EUR 0.2 million (In 2023:
EUR 0.9 million).
- EBITDA was EUR -1.0 million (EUR -1.5 million).
- Operating profit was EUR -1.7 million (EUR -2.4 million).
- The profit before taxes was EUR -2.0 million (EUR -3.2
million).
- Profit for the period was EUR -2.0 million (EUR -3.2
million).
- Undiluted earnings per share were EUR -0.65 (EUR -1.41).
- Diluted earnings per share were EUR -0.65 (EUR -1.41).
FINANCING
Cash flow from business operations before investments in January
– June was EUR -0.6 million (EUR -2.0 million). Trade receivables
at the end of the reporting period were EUR 0.1 million (EUR 0.4
million). Net financial items amounted to EUR 0.3 million (EUR 0.8
million). At the end of June, the equity ratio of Valoe Group was
-82.6 per cent (-43.3 %) and equity per share was EUR -3.6 (EUR
-2.9). The equity ratio including capital loans was -47.6 per cent
(-20.0 %). At the end of the reporting period, the Group’s liquid
assets totalled EUR 0.01 million.
In July 2023, we issued a convertible bond of up to EUR 0.6
million. The Convertible Bond 1/2023 is a capital loan. On 15
August 2023, we first increased the maximum amount of the
Convertible Bond 1/2023 to EUR 1.0 million, and then, on 3 November
2023, to EUR 3.0 million. At the end of the reporting period, on 21
December 2023, the subscription price of the Convertible Bond
1/2023 was reduced to EUR 0.74 and the subscription period was
extended until 31 July 2024. At the end for September 2024, the
subscription period has again been extended until 31 December 2024.
The loan period shall commence on the payment date and expire on 30
June 2025. An annual interest of eight (8) percent shall be paid to
the capital of the Convertible Bond. The promissory note holder of
the Convertible Bond 1/2023 has the right to convert the promissory
note into the shares of the company pursuant to the terms of the
Convertible Bond 1/2023. The subscription price of one (1) share of
the company shall be EUR 0.74 per share. The conversion period
began on 1 December 2023 and expires on 30 June 2025.
RESEARCH & DEVELOPMENT AND INVESTMENTS
The Group’s research and development costs amounted to EUR 1.1
million (EUR 1.8 million) during the reporting period.
Gross investments during January – June period amounted to EUR 7
thousand (EUR 1.2 million).
PERSONNEL
At the end of June 2024, the Group employed 42 (52) people, out
of which 12 employees worked in Lithuania and the rest in Finland.
During the reporting period, the Group’s salaries and fees totalled
EUR 0.6 million (EUR 1.1 million).
SHARES AND SHAREHOLDERS
At the end of the reporting period, Valoe’s share capital
amounted to EUR 80,000.00 and the number of shares was 3,116,630.
The company has one series of shares, which confer equal rights in
the company. On 30 June 2024 Valoe had 29,590 treasury
shares.
The company had a total of 16,859 shareholders at the end of
June 2024, and 3.8 per cent of the shares were owned by foreigners.
The ten largest shareholders held 31.8 per cent of the company’s
shares on 30 June 2024.
The largest shareholders on 28 June 2024
1 |
SKANDINAVISKA
ENSKILDA BANKEN AB (PUBL) |
184.642 |
5,9 |
2 |
NEFCO |
115.741 |
3,7 |
3 |
INVESTMENT
KETOUMAN OY |
106.918 |
3,4 |
4 |
APTEEKKIEN
ELÄKEKASSA |
106.044 |
3,4 |
5 |
SAVISALO
IIKKA |
89.056 |
2,9 |
6 |
JOCER OY
AB |
88.169 |
2,8 |
7 |
OLLILA
JORMA |
82.063 |
2,6 |
8 |
OY INGMAN
FINANCE AB |
79.985 |
2,6 |
9 |
SAVISALO
HANNU |
77.877 |
2,5 |
10 |
EYEMAKER’S
FINLAND OY |
61.540 |
2,0 |
|
OTHERS |
2.124.595 |
68,2 |
|
TOTAL |
3.116.630 |
100,0 |
The members of the Board of Directors and the President and CEO,
either directly or through companies under their control, held a
total of 267,134 shares in the company on 30 June 2024,
representing about 8.6 per cent of the company’s shares. At the end
of the period Iikka Savisalo, Valoe’s Managing Director, either
directly or through companies under his control, held a total of
187,918 shares in the company.
Trading in the Valoe’s shares has been suspended since 5
December 2023.
SHARE ISSUE AUTHORIZATIONS IN FORCE
The company has a share issue authorization in force granted by
the Annual General Meeting 2024 according to which The Board of
Directors is authorized to decide on a share issue with and/or
without payment, either in one or in several occasions, including
right to resolve on option rights and other rights entitling to
shares pursuant to the Chapter 10, Section 1 of the Finnish
Companies Act so that the number of new shares could increase by a
total maximum amount of 4,500,000 shares. The authorization does
not exclude the Board’s right to decide also on directed issue of
shares or option rights and other special rights. The authorization
may be used for important arrangements from the company’s point of
view e.g. to strengthen the capital structure, to finance
investments, for acquisitions and business transactions or other
business arrangements, or to expand ownership structure, or for
other purposes resolved by the Board involving a weighty financial
reason for issuing shares or option rights or special rights
entitling to shares pursuant to the Chapter 10, Section 1 of the
Finnish Companies Act. The authorization is in force until 30 June
2025.
RISKS AND UNCERTAINTIES
Valoe’s most significant risk is securing the necessary
financing and its sufficiency. Restructuring proceedings were
commenced at Valoe on 22 January 2024. The Administrator’s
preliminary report concludes that the company’s business has
potential that can be rehabilitated through the restructuring
proceedings. However, the company’s restructuring proceedings will
require finding a financing solution for the duration of the
proceedings. In addition, the company should find a financing or
ownership solution to secure its operating conditions for a longer
period of time. The Board of Directors of Valoe Corporation has
discovered that the company has negative equity and has filed a
notice of the loss of share capital with the Finnish Trade Register
on 27 May 2024. If the company fails to secure the necessary
financing, the restructuring proceedings may have to be suspended,
and the company may be declared bankrupt.
The Company's financial situation is critical and requires the
rapid implementation of a sufficiently comprehensive financing
solution. If a financing solution is not secured quickly enough,
the restructuring process may be suspended, and the Company may be
declared bankrupt.
The statements and projections in this Report and in Valoe’s
strategy are targeted to the future and based on the management’s
current estimates. Therefore, they involve risks and uncertainty by
their nature and may be affected by changes in the general
financial situation and in Valoe’s and its customers’ business
environment.
In Mikkeli, 30 September 2024
Valoe Corporation
Board of Directors
Further information:
Iikka Savisalo, CEO
Tel. +358 40 521 6082, Iikka.savisalo@valoe.com
Consolidated statement of comprehensive income |
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
000 EUR |
|
1-6/2024 |
1-6/2023 |
1-12/2023 |
|
|
|
|
|
Net sales |
|
167 |
910 |
1 108 |
Cost of
sales |
-242 |
-870 |
-1 384 |
Gross profit |
-75 |
40 |
-276 |
|
|
|
|
|
Other operating
income |
29 |
43 |
69 |
Product
development expenses |
-1 054 |
-1 778 |
-3 190 |
Sales and
marketing expenses |
-120 |
-207 |
-354 |
Administrative
expenses |
-520 |
-448 |
-884 |
Other operating
expenses |
0 |
-30 |
-144 |
|
|
|
|
|
Operating
profit |
-1 741 |
-2 380 |
-4 779 |
|
|
|
|
|
Financial
income |
0 |
0 |
1 |
Financial
expenses |
-276 |
-846 |
-1 998 |
|
|
|
|
|
Profit before
taxes |
-2 016 |
-3 225 |
-6 776 |
|
|
|
|
|
Income taxes |
0 |
0 |
0 |
|
|
|
|
|
Profit/loss for the period |
-2 016 |
-3 225 |
-6 776 |
|
|
|
|
|
Profit/loss
attributable to: |
|
|
|
Shareholders of
the parent company |
-2 016 |
-3 225 |
-6 776 |
|
|
|
|
|
Earnings/share
(basic), eur |
-0,65 |
-1,41 |
-2,58 |
Earnings/share
(diluted), eur |
-0,65 |
-1,41 |
-2,58 |
|
|
|
|
|
Total comprehensive income for the period |
-2 016 |
-3 225 |
-6 776 |
|
|
|
|
|
Total
comprehensive income attributable to: |
|
|
|
Shareholders of
the parent company |
-2 016 |
-3 225 |
-6 776 |
|
|
|
|
|
|
|
|
|
|
THE SECOND
QUARTER OF 2024 |
|
|
|
|
|
|
|
|
1 000 EUR |
|
4-6/2024 |
4-6/2023 |
1-12/2023 |
|
|
|
|
|
Net sales |
|
65 |
498 |
1 108 |
|
|
|
|
|
Operating
profit |
-507 |
-628 |
-3 218 |
|
|
|
|
|
EBIDTA |
|
-893 |
-1 059 |
-4 779 |
|
|
|
|
|
Profit/loss for
the period |
-934 |
-1 354 |
-6 776 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated statement of financial position |
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
000 EUR |
|
30.6.2024 |
30.6.2023 |
31.12.2023 |
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
Non-current
assets |
|
|
|
Property, plant
and equipment |
10 842 |
11 293 |
11 222 |
Consolidated
goodwill |
441 |
441 |
441 |
Other intangible
assets |
894 |
1 628 |
1 283 |
Available-for-sale
investment |
9 |
9 |
9 |
Non-current
receivables |
336 |
336 |
336 |
Total
non-current assets |
12 523 |
13 708 |
13 292 |
|
|
|
|
|
Current assets |
|
|
|
|
Inventories |
|
363 |
392 |
330 |
Trade and other
non-interest-bearing receivables |
590 |
1 794 |
953 |
Cash and cash
equivalents |
12 |
15 |
3 |
Total
current assets |
965 |
2 200 |
1 286 |
|
|
|
|
|
Total assets |
|
13 488 |
15 908 |
14 577 |
|
|
|
|
|
|
|
|
|
|
EQUITY AND
LIABILITIES |
|
|
|
|
|
|
|
|
Equity
attributable to shareholders of the parent company |
|
|
Share capital |
|
80 |
80 |
80 |
Other reserves |
|
38 736 |
37 691 |
38 736 |
Retained earnings |
|
-49 857 |
-44 423 |
-47 890 |
Total equity |
|
-11 042 |
-6 652 |
-9 075 |
|
|
|
|
|
Non-current
liabilities |
|
|
|
Non-current loans |
|
5 444 |
6 606 |
6 248 |
Non-current
subordinated loans |
777 |
0 |
446 |
Other non-current
liabilities |
0 |
505 |
252 |
Total
non-current liabilities |
6 221 |
7 111 |
6 946 |
|
|
|
|
|
Current
liabilities |
|
|
|
|
Current
interest-bearing liabilities |
7 689 |
6 589 |
6 790 |
Current
subordinated loans |
3 904 |
3 583 |
3 904 |
Trande and other
payables |
6 612 |
5 172 |
5 907 |
Current provisions |
|
104 |
104 |
104 |
Total
current liabilities |
18 309 |
15 449 |
16 706 |
|
|
|
|
|
Total liabilities |
|
24 530 |
22 560 |
23 652 |
|
|
|
|
|
Equity and liabilities total |
13 488 |
15 908 |
14 577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated statement of cash flows |
|
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
000 EUR |
|
1-6/2024 |
1-6/2023 |
1-12/2023 |
|
|
|
|
|
|
Cash flow from
operating activities |
|
|
|
|
Income statement profit/loss before taxes |
|
-2 016 |
-3 225 |
-6 776 |
|
|
|
|
|
|
Non-monetary items adjusted on income statement |
|
|
|
|
|
Depreciation and
impairment |
+ |
776 |
847 |
1 561 |
|
Unrealized exchange rate gains
(-) and losses (+) |
+/- |
0 |
0 |
1 |
|
Other non-cash
transactions |
+/- |
3 |
0 |
88 |
|
Financial income and
expense |
+ |
275 |
846 |
1 996 |
Total
cash flow before change in working capital |
|
-962 |
-1 533 |
-3 129 |
|
|
|
|
|
|
Change in
working capital |
|
|
|
|
|
Increase (-) / decrease (+) in
inventories |
|
-33 |
-31 |
31 |
|
Increase (-) /
decrease (+) in trade and other receivables |
21 |
-379 |
-83 |
|
Increase (+) /
decrease (-) in trade and other payables |
458 |
172 |
846 |
Change
in working capital |
|
445 |
-238 |
794 |
|
|
|
|
|
|
Adjustment of
financial items and taxes to cash-based accounting |
|
|
|
Interest paid |
- |
31 |
225 |
220 |
|
Other financial items |
- |
8 |
12 |
29 |
Financial
items and taxes |
|
-39 |
-237 |
-249 |
NET CASH FLOW
FROM BUSINESS OPERATIONS |
|
-556 |
-2 008 |
-2 584 |
|
|
|
|
|
|
CASH FLOW FROM
INVESTING ACTIVITIES |
|
|
|
|
|
Investments in tangible and
intangible assets |
- |
7 |
152 |
358 |
|
Grants received |
+ |
297 |
0 |
0 |
NET
CASH FLOW FROM INVESTMENTS |
|
289 |
-152 |
-358 |
|
|
|
|
|
|
CASH FLOW FROM
FINANCING ACTIVITIES |
|
|
|
|
|
Financing arrangement with
Winance and Riverfort |
+ |
0 |
2 564 |
2 554 |
|
Proceeds from
non-current borrowings |
+ |
350 |
0 |
500 |
|
Proceeds from current
borrowings |
+ |
143 |
351 |
818 |
|
Repayment of current
borrowings |
- |
218 |
975 |
1 162 |
NET
CASH FLOW FROM FINANCING ACTIVITIES |
|
276 |
1 940 |
2 709 |
|
|
|
|
|
|
INCREASE (+) OR
DECREASE (-) IN CASH FLOW |
|
9 |
-221 |
-233 |
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated statement of changes in equity |
|
(unaudited) |
|
|
|
|
1
000 EUR |
Share capital |
Distributable non-restricted equity fund |
Retained earnings |
Total equity |
31.12.2023 |
80 |
38 736 |
-47 890 |
-9 075 |
Profit/loss for the period |
- |
- |
-2 016 |
-2 016 |
Translation difference, comprehensive income |
- |
- |
0 |
0 |
Transactions with owners: |
|
|
|
|
Own equity component of the convertible bond |
0 |
0 |
49 |
49 |
30.6.2024 |
80 |
38 736 |
-49 857 |
-11 042 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
000 EUR |
Share capital |
Distributable non-restricted equity fund |
Retained earnings |
Total equity |
31.12.2022 |
80 |
34 694 |
-41 051 |
-6 277 |
Profit/loss for the period |
- |
- |
-3 225 |
-3 225 |
Translation difference, comprehensive income |
- |
- |
0 |
0 |
Transactions with owners: |
|
|
|
|
Sale of own shares - Winance |
0 |
465 |
0 |
465 |
Riverfort and other arrangements |
0 |
775 |
0 |
775 |
Own equity component of the convertible bond |
0 |
0 |
-146 |
-146 |
30.6.2023 |
80 |
37 691 |
-44 423 |
-6 652 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Key
figures |
|
|
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
1
000 EUR |
1-6/2024 |
1-6/2023 |
1-12/2023 |
|
|
|
|
Net sales |
167 |
910 |
1 108 |
Operating profit |
-1 741 |
-2 380 |
-4 779 |
% of net sales |
-1045,1 % |
-261,5 % |
-431,3 % |
EBITDA |
-965 |
-1 533 |
-3 218 |
% of net sales |
-579,2 % |
-168,5 % |
-290,4 % |
Profit before taxes |
-2 016 |
-3 225 |
-6 776 |
% of net sales |
-1210,5 % |
-354,5 % |
-611,5 % |
|
|
|
|
Balance Sheet value |
13 488 |
15 908 |
14 577 |
Equity ratio, % |
-82,6 % |
-43,3 % |
-62,3 % |
Net gearing, % |
neg. |
neg. |
neg. |
Gross investments |
7 |
1 191 |
1 622 |
% of net sales |
4,3 % |
130,9 % |
146,4 % |
Research and development
costs |
1 054 |
1 778 |
3 190 |
% of net sales |
633,0 % |
195,4 % |
287,9 % |
|
|
|
|
Order book |
58 |
192 |
58 |
|
|
|
|
Personnel on average |
22 |
52 |
48 |
Personnel at the end of the
period |
42 |
52 |
54 |
|
|
|
|
Non-interest-bearing
liabilities |
6 612 |
5 172 |
5 907 |
Interest-bearing
liabilities |
17 814 |
17 284 |
17 640 |
|
|
|
|
Share key indicators |
|
|
|
Earnings/share (basic) |
-0,65 |
-1,41 |
-2,58 |
Earnings/share (diluted) |
-0,65 |
-1,41 |
-2,58 |
Equity/share |
-3,54 |
-2,91 |
-3,45 |
P/E ratio |
n/a |
-3,97 |
-0,36 |
Highest price |
n/a |
12,00 |
12,00 |
Lowest price |
n/a |
4,20 |
0,55 |
Average price |
n/a |
6,20 |
3,61 |
Closing price (*) |
0,93 |
5,60 |
0,93 |
Market
capitalisation, at the end of the period, MEUR |
2,9 |
14,5 |
2,9 |
|
|
|
|
*Share trading was suspended on December 5, 2023 after the company
submitted a debt restructuring application. |
|
|
|
|
|
|
|
|
Calculation of Key
Figures |
|
|
|
|
|
|
|
|
|
|
EBITDA, %: |
Operating profit + depreciation + impairment |
|
Net sales |
|
|
|
|
|
|
Equity ratio, %: |
Total equity x 100 |
|
|
|
Total assets - advances received |
|
|
|
|
|
Net gearing, %: |
Interest-bearing liabilities - cash and cash
equivalents |
|
and marketable securities x 100 |
|
|
Shareholders' equity + non-controlling interests |
|
|
|
|
Earnings/share (EPS): |
Profit/loss for the period to the owner of the parent company |
|
Average number of shares adjusted for share issue |
|
at the end of the financial year |
|
|
|
|
|
Equity/share: |
Equity attributable to shareholders of the parent company |
|
Undiluted number of shares on the balance sheet date |
|
|
|
|
P/E ratio: |
Price on the
balance sheet date |
|
|
Earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related party
transactions |
|
|
|
(unaudited) |
|
|
|
|
|
|
|
The Group has sold and purchased goods and services from companies
in which the majority holding and/or power of decision granting
control of the company is held by members of the Group's related
parties. Sales of goods and services carried out with related
parties are based on market prices. |
|
|
|
|
The Group
entered into the following transactions with related
parties: |
|
|
|
|
|
|
1
000 EUR |
1-6/2024 |
1-6/2023 |
1-12/2023 |
|
|
|
|
Sales of goods and
services |
|
|
|
Savcor Oy - production
services |
18 |
0 |
0 |
Total |
18 |
0 |
0 |
|
|
|
|
Purchases of goods and
services |
|
|
|
SCI Invest Oy
- rent |
0 |
24 |
36 |
Basso J., business management
services in Lithuania |
50 |
61 |
118 |
SCI-Finance Oy - marketing and
administration services |
52 |
36 |
100 |
Savcor Technologies Oy -
marketing and admin services |
52 |
52 |
107 |
Savcor Oy - financial
management services |
3 |
8 |
13 |
ISC Bioheat Oy - marketing
services |
0 |
0 |
10 |
Others |
0 |
4 |
4 |
Total |
157 |
185 |
388 |
|
|
|
|
Interest expenses and other
financial expenses |
|
|
|
SCI-Finance Oy |
63 |
90 |
127 |
Savcor Technologies Oy |
0 |
3 |
9 |
Savcor Oy |
2 |
1 |
4 |
Others |
0 |
1 |
1 |
Total |
65 |
95 |
141 |
|
|
|
|
Other current liabilities to
related parties |
216 |
120 |
211 |
Current interest payable to
related parties |
24 |
9 |
22 |
Trade payables
and other non-interest-bearing liabilities to related parties |
1 164 |
436 |
929 |
|
|
|
|
Trade and other current
receivables from related parties |
56 |
37 |
38 |
|
|
|
|
Savcor Technologies Oy and Savcor Face Ltd are companies under
control of Iikka Savisalo, Valoe's CEO, Hannu Savisalo, Valoe's
Chairman of the Board and Tuukka Savisalo, Valoe's Management Team
Member. |
|
|
|
|
Savcor Oy is a company under control of Iikka Savisalo, Valoe's CEO
and Hannu Savisalo, Valoe's Chairman of the Board. |
|
|
|
|
SCI-Finance Oy is a company under control of Hannu Savisalo,
Valoe's Chairman of the Board. |
|
|
|
|
SCI Invest Oy is a company under control of Iikka Savisalo, Valoe's
CEO and Tuukka Savisalo, Valoe's Managment Team Member. |
|
|
|
|
1
000 EUR |
1-6/2024 |
1-6/2023 |
1-12/2023 |
|
|
|
|
Wages and
remuneration |
|
|
|
Salaries of the management and
Board |
238 |
190 |
447 |
|
|
|
|
|
|
|
|
Fair
values |
|
|
(unaudited) |
|
|
|
|
|
|
Carrying amount |
Fair value |
1
000 EUR |
30.6.2024 |
30.6.2024 |
|
|
|
Financial assets |
|
|
Available-for-sale
investments |
9 |
9 |
Trade and other
receivables |
590 |
590 |
Cash and cash equivalents |
12 |
12 |
|
|
|
|
|
|
Financial
liabilities |
|
|
R&D loans,
non-current |
5 444 |
5 444 |
Non-current subordinated
loans |
777 |
777 |
Current subordinated loan |
3 904 |
3 904 |
Loans from financial
institutions, current |
5 045 |
5 045 |
R&D loan, current |
1 560 |
1 560 |
Other loans, current |
486 |
486 |
Other liabilities,
current |
597 |
597 |
Trade payables and other
non-interest-bearing liabilities |
3 400 |
3 400 |
|
|
|
The
fair value of non-current liabilities is expected to correspond to
the carrying amount and recognized to their fair value when
recorded. There has been no significant change in common interest
rate after the withdrawal of the loans. |
|
|
|
Other
current liabilities include EUR 0.5 million of liabilities arising
from the IFRS 16 standard. |
|
|
|
The
company filed an application for restructuring on 5 December 2023
and the District Court of Pohjois-Savo, Finland, decided on the
commencement of the restructuring proceedings on 22 January 2024.
Debts incurred before December 5, 2023 will be processed in
accordance with the restructuring program. |
|
|
|
|
|
|
|
|
|
Change in intangible and tangible assets |
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
1
000 EUR |
30.6.2024 |
30.6.2023 |
31.12.2023 |
|
|
|
|
Includes
tangible assets, consolidated goodwill and other intangible
assets |
|
|
|
|
|
|
|
Carrying amount, beginning of
period |
12 946 |
13 062 |
13 062 |
Depreciation and
impairment |
-776 |
-847 |
-1 561 |
Additions |
7 |
1 155 |
1 453 |
Disposals |
0 |
-8 |
-8 |
Carrying amount, end of
period |
12 177 |
13 362 |
12 946 |
|
|
|
|
The assets and liabilities of the contracts have been recognized in
IFRS 16 leases and properties at the date of transition 1 Jan
2019. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingent liabilities |
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
1
000 EUR |
30.6.2024 |
30.6.2023 |
31.12.2023 |
|
|
|
|
Assets pledged for the
company |
|
|
|
Loans from financial
institutions |
2 545 |
3 026 |
2 545 |
Other liabilities |
1 059 |
98 |
901 |
|
|
|
|
Promissory notes secured
by pledge |
8 060 |
2 060 |
8 060 |
Other securities
provided |
2 097 |
2 394 |
2 097 |
|
|
|
|
|
|
|
|
Operating lease
liabilities |
|
|
|
Payable within one
year |
0 |
15 |
0 |
Payable over one
year |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
Valoe (TG:7RT)
Historical Stock Chart
From Nov 2024 to Dec 2024
Valoe (TG:7RT)
Historical Stock Chart
From Dec 2023 to Dec 2024